ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
ADARx Pharmaceuticals, Inc.
$17.63−0.02 (-0.11%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
1 of ADARx Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |